Amalgamated Bank boosted its stake in Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 34.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,348 shares of the company’s stock after buying an additional 10,991 shares during the quarter. Amalgamated Bank’s holdings in Endo International PLC were worth $484,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. HL Financial Services LLC boosted its stake in Endo International PLC by 1.0% in the 2nd quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock valued at $590,000 after buying an additional 500 shares in the last quarter. Meeder Asset Management Inc. boosted its stake in Endo International PLC by 1.4% in the 2nd quarter. Meeder Asset Management Inc. now owns 48,699 shares of the company’s stock valued at $544,000 after buying an additional 677 shares in the last quarter. Capstone Asset Management Co. boosted its stake in Endo International PLC by 3.1% in the 2nd quarter. Capstone Asset Management Co. now owns 32,035 shares of the company’s stock valued at $358,000 after buying an additional 960 shares in the last quarter. Arizona State Retirement System raised its position in Endo International PLC by 1.5% in the 2nd quarter. Arizona State Retirement System now owns 83,700 shares of the company’s stock valued at $935,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Oakbrook Investments LLC raised its position in Endo International PLC by 8.2% in the 2nd quarter. Oakbrook Investments LLC now owns 17,100 shares of the company’s stock valued at $191,000 after purchasing an additional 1,300 shares during the last quarter. 90.71% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Endo International PLC (ENDP) Position Increased by Amalgamated Bank” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/endo-international-plc-endp-position-increased-by-amalgamated-bank/1609400.html.

In related news, CFO Blaise Coleman purchased 6,500 shares of the business’s stock in a transaction on Tuesday, August 15th. The stock was acquired at an average price of $7.89 per share, for a total transaction of $51,285.00. Following the purchase, the chief financial officer now owns 13,729 shares of the company’s stock, valued at $108,321.81. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Terrance J. Coughlin purchased 20,000 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were bought at an average price of $7.70 per share, with a total value of $154,000.00. Following the purchase, the chief operating officer now directly owns 181,369 shares in the company, valued at approximately $1,396,541.30. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 36,000 shares of company stock valued at $279,460. 0.50% of the stock is currently owned by company insiders.

Several brokerages have issued reports on ENDP. Guggenheim began coverage on Endo International PLC in a research report on Saturday, June 17th. They issued a “hold” rating and a $12.00 price objective for the company. Canaccord Genuity set a $10.00 price objective on Endo International PLC and gave the company a “hold” rating in a research report on Monday, August 14th. Deutsche Bank AG cut their price objective on Endo International PLC from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, July 7th. Oppenheimer Holdings, Inc. reiterated a “hold” rating on shares of Endo International PLC in a research report on Thursday, June 8th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $9.00 price objective (down previously from $15.00) on shares of Endo International PLC in a research report on Wednesday, August 9th. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and five have issued a buy rating to the company. Endo International PLC presently has an average rating of “Hold” and an average target price of $12.80.

Endo International PLC (ENDP) opened at 8.82 on Thursday. Endo International PLC has a 52-week low of $7.41 and a 52-week high of $21.87. The firm’s market capitalization is $1.97 billion. The stock’s 50 day moving average price is $8.69 and its 200 day moving average price is $10.64.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last issued its earnings results on Tuesday, August 8th. The company reported $0.93 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.19. The company had revenue of $875.73 million during the quarter, compared to the consensus estimate of $832.66 million. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period last year, the business posted $0.86 EPS. On average, analysts predict that Endo International PLC will post $3.52 EPS for the current fiscal year.

Endo International PLC Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.